New England Peptide / Peptides International just made available new recombinant proteins related to the COVID-19 (Coronavirus).
These, along will other coronavirus strains and related items, are available through this link. We would also like you alert you to our brand new page: The COVID-19 Information Station, designed to be an aggregator of all our related COVID-19 info.
A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the city of Wuhan, Hubei province of China on December 2019.
The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity, thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans.
RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.
The new products with their respective links are:
Novel Coronavirus 2019-nCoV Spike Glycoprotein-S1, Recombinant
Novel Coronavirus 2019-nCoV Spike Glycoprotein-S2, Recombinant
Coronavirus 2019 Nucleocapsid Recombinant
CoV Spike E-Mosaic
Coronavirus 2019 Spike E-Mosaic Recombinant
Coronavirus 2019 Nucleocapsid Mosaic Recombinant
Related topics: ACE2, Angiotensin, Angiotensin TrypTides, Bradykinin, Bradykinin TrypTides, Influenza Matrix Protein M1 (58-66), camostat mesylate, custom antibodies, OVA Peptide (257-264), putative orf1ab polyprotein (3233-3247) [SARS coronavirus]
*background content supplied by ProSpec